Rheumatoid Arthritis Drugs Market in Japan 2011-2015 - Latest Report
The Rheumatoid Arthritis market in Japan is expected to grow at a CAGR of 29.2 percent over the period 2011–2015. One of the key factors contributing to this market growth is the high prevalence rate of patients suffering from rheumatoid arthritis. The Rheumatoid Arthritis Drugs market in Japan has also been witnessing a trend of increasing number of collaborations among vendors. However, stringent regulatory requirements for approval of drugs in Japan could pose a challenge to the growth of this...
View full press release